Vanguard Capital Management
VNRX icon

Vanguard Capital Management’s VolitionRx Ltd VNRX Stock Holding History

Vanguard Capital Management’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68.4K Hold
50,684
– – ﹤0.01% 3911
2026
Q1 		$205K Buy
+50,684
New +$242K ﹤0.01% 3797

Other funds holding VNRX

LM
Luminus Management Houston, Texas $146M AUM 27.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Vanguard Capital Management's VNRX Position: Q2 2026 in Review

Vanguard Capital Management held its VolitionRx Ltd (VNRX) position steady in Q2 2026 at 50,684 shares worth $68.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3911.

Vanguard Capital Management first reported a position in VNRX in Q1 2026 and has held it in 2 quarters since. The position peaked at $205K in Q1 2026. 25 funds tracked by Wall St. Rank hold VNRX as of Q2 2026.

  • Vanguard Capital Management held 50,684 shares of VolitionRx Ltd worth $68.4K as of Q2 2026.
  • Vanguard Capital Management left its VolitionRx Ltd share count unchanged in Q2 2026.
  • VolitionRx Ltd made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3911 holding.
  • Vanguard Capital Management first reported a position in VolitionRx Ltd in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's VolitionRx Ltd position peaked at $205K in Q1 2026.
  • 25 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.